To determine the clinical significance of an increase in various fragmented forms of insulin-like growth factor binding protein-1 (IGFBP-1) in amniotic fluid (AF), a retrospective cohort study was conducted in 103 consecutive patients with preterm labor and intact membranes. Amniotic fluid samples were cultured for aerobic and anaerobic bacteria, and mycoplasmas, and then assayed for matrix metalloproteinase-8. Fragmented-to-intact IGFBP-1 ratios were evaluated by densitometric analysis of Western blot assays. Intact IGFBP-1 (30 kDa) and 21, 17, and 12 kDa fragments were detected in AF. Median ratios of fragmented-to-intact IGFBP-1 were higher in patients whose neonates had significant morbidity than in those whose neonates did not (P < .05), in patients spontaneously delivered within 2 and 7 days from amniocentesis than in those delivered after 2 and 7 days (P < .05), and in patients with intra-amniotic infection/inflammation than in those without (P < .001). Collectively, fragmented IGFBP-1 in AF may be indicators for adverse perinatal outcomes.
GomezRGhezziFRomeroRMunozHTolosaJERojasI. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol. 1995;22(2):281–342.
2.
YoonBHRomeroRMoonJB. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2001;185(5):1130–1136.
3.
GoldenbergRLHauthJCAndrewsWW. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342(20):1500–1507.
4.
RomeroREspinozaJKusanovicJP. The preterm parturition syndrome. BJOG. 2006;113(suppl 3):17–42.
HillierSLWitkinSSKrohnMAWattsDHKiviatNBEschenbachDA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol. 1993;81(6):941–948.
7.
YoonBHRomeroRKimCJ. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995;172(3):960–970.
8.
YoonBHRomeroRJunJK. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1997;177(4):825–830.
9.
YoonBHRomeroRKimCJ. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol. 1997;177(2):406–411.
10.
YoonBHRomeroRParkJS. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000;182(3):675–681.
11.
HagbergHMallardCJacobssonB. Role of cytokines in preterm labour and brain injury. BJOG. 2005;112(suppl 1):16–18.
12.
RamseyPSLiemanJMBrumfieldCGCarloW. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 2005;192(4):1162–1166.
13.
NormannELacaze-MasmonteilTEatonFSchwendimannLGressensPThebaudB. A novel mouse model of Ureaplasma-induced perinatal inflammation: effects on lung and brain injury. Pediatr Res. 2009;65(4):430–436.
14.
RomeroRYoonBHMazorM. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1993; 169(4):805–816.
15.
VaisbuchERomeroRErezO. Total hemoglobin concentration in amniotic fluid is increased in intraamniotic infection/inflammation. Am J Obstet Gynecol. 2008;199(4):426 e1–e7.
16.
PuchnerTEgarterCWimmerCLederhilgerFWeichselbraunI. Amniotic fluid interleukin-8 as a marker for intraamniotic infection. Arch Gynecol Obstet. 1993;253(1):9–14.
17.
GreigPCHerbertWNRobinetteBLTeotLA. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol. 1995;173(4):1223–1227.
18.
KaraMOzdenSAriogluPCetinA. The significance of amniotic fluid interleukin-6 levels in preterm labour. Aust N Z J Obstet Gynaecol. 1998;38(4):403–406.
19.
HsuCDMeaddoughEAversaK. Elevated amniotic fluid levels of leukemia inhibitory factor, interleukin 6, and interleukin 8 in intra-amniotic infection. Am J Obstet Gynecol. 1998;179(5):1267–1270.
20.
Nhan-ChangCLRomeroRKusanovicJP. A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med. 2008;21(11):763–775.
21.
RomeroRQuinteroREmamianM. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol. 1987;157(6):1454–1460.
22.
LocksmithGJClarkPDuffPSchultzGS. Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection. Obstet Gynecol. 1999;94(1):1–6.
HarirahHDoniaSEHsuCD. Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection. Obstet Gynecol. 2002;99(1):80–84.
25.
GravettMGNovyMJRosenfeldRG. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004;292(4):462–469.
26.
BujoldERomeroRKusanovicJP. Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry. J Matern Fetal Neonatal Med. 2008;21(10):697–713.
27.
FowlerDJNicolaidesKHMiellJP. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum Reprod Update. 2000;6(5):495–504.
KoistinenRKalkkinenNHuhtalaMLSeppalaMBohnHRutanenEM. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology. 1986;118(4):1375–1378.
30.
BellSCPatelSRJacksonJAWaitesGT. Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein. J Endocrinol. 1988;118(2):317–328.
31.
MartinaNAKimEChitkaraUWathenNCChardTGiudiceLC. Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab. 1997;82(6):1894–1898.
32.
ShimSSRomeroRHongJS. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 2004;191(4):1339–1345.
33.
ParkJSRomeroRYoonBH. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol. 2001;185(5):1156–1161.
34.
LeeSEHanBDParkISRomeroRYoonBH. Evidence supporting proteolytic cleavage of insulin-like growth factor binding protein-1 (IGFBP-1) protein in amniotic fluid. J Perinat Med. 2008;36(4):316–323.
35.
WangHChenBChowSC. Sample size determination based on rank tests in clinical trials. J Biopharm Stat. 2003;13(4):735–751.
BischofPMeisserACampanaATsengL. Effects of decidua-conditioned medium and insulin-like growth factor binding protein-1 on trophoblastic matrix metalloproteinases and their inhibitors. Placenta. 1998;19(7):457–464.
40.
RomeroRYoonBHMazorM. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 1993;169(4):839–851.
41.
JacobssonBMattsby-BaltzerIAnderschB. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet Gynecol Scand. 2003;82(2):120–128.
42.
YoonBHRomeroRLimJH. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol. 2003;189(4):919–924.
43.
TisiDKLiuXJWykesLJSkinnerCDKoskiKG. Insulin-like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr. 2005;135(7):1667–1672.
44.
ChardT. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul. 1994;4(3):91–100.
45.
VerhaegheJVan HerckEBillenJMoermanPVan AsscheFAGiudiceLC. Regulation of insulin-like growth factor-I and insulin-like growth factor binding protein-1 concentrations in preterm fetuses. Am J Obstet Gynecol. 2003; 188(2):485–491.
46.
ChevallierBLagardeADegrelleHBelaisch-AllartJGiraudetPGalletJP. Insulin-like growth factor binding protein 1 level in amniotic fluid: correlation with birth weight. Biol Neonate. 1998;73(6):404–406.
47.
Hakala-Ala-PietilaTHKoistinenRASalonenRKSeppalaMT. Elevated second-trimester amniotic fluid concentration of insulin-like growth factor binding protein-1 in fetal growth retardation. Am J Obstet Gynecol. 1993;169(1):35–39.
48.
CrosseyPAPillaiCCMiellJP. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest. 2002;110(3):411–418.
49.
NingYWilliamsMAVadachkoriaSMuy-RiveraMFrederickIOLuthyDA. Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin Biochem. 2004;37(11):968–973.
50.
VattenLJNilsenTIJuulAJeanssonSJenumPAEskildA. Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol. 2008;158(1):101–105.
51.
Hansen-PuppIHellstrom-WestasLCilioCMAnderssonSFellmanVLeyD. Inflammation at birth and the insulin-like growth factor system in very preterm infants. Acta Paediatr. 2007;96(6):830–836.
52.
MarchiniGHagenasLKocoska-MarasLBerggrenVHanssonLO. Insulin-like growth factor binding protein-1 and interleukin-6 are markers of fetal stress during parturition at term gestation. J Pediatr Endocrinol Metab. 2005;18(8):777–783.
53.
FowlkesJL. Insulinlike growth factor-binding protein proteolysis an emerging paradigm in insulinlike growth factor physiology. Trends Endocrinol Metab. 1997;8(8):299–306.
GibsonJMAplinJDWhiteAWestwoodM. Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod. 2001;7(1):79–87.
56.
DiamandiAMistryJKrishnaRGKhosraviJ. Immunoassay of insulin-like growth factor-binding protein-3 (IGFBP-3): new means to quantifying IGFBP-3 proteolysis. J Clin Endocrinol Metab. 2000;85(6):2327–2333.
